Cargando…

310 Treatment Considerations of Anti-GBM and ANCA Overlap Syndrome: First Do No Harm

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027991/ http://dx.doi.org/10.1053/j.ajkd.2023.01.312

Ejemplares similares

Pulmonary-Renal Syndrome with Negative ANCAs and Anti-GBM Antibody
por: Yamaguchi, Hiroshi, et al.
Publicado: (2013)

Crescentic Glomerulonephritis with Anti-GBM and p-ANCA Antibodies
por: Javed, Tariq, et al.
Publicado: (2012)

Double-Positive Anti-GBM and ANCA-MPO Vasculitis Presenting With Crescentic Glomerulonephritis
por: Pacheco, Mariana, et al.
Publicado: (2021)

Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients
por: Hu, Xueling, et al.
Publicado: (2022)

Crescentic glomerulonephritis with dual positive anti-GBM and C-ANCA/PR3 antibodies
por: Omotoso, Bolanle A., et al.
Publicado: (2016)

A Case of Simultaneous, Biopsy-Proven, Classic, ANCA-Positive Wegener's Granulomatosis and Anti-GBM Disease, but without Detectible Circulating Anti-GBM Antibodies
por: Gmurczyk, Aleksandra, et al.
Publicado: (2010)

Sequential development of ANCA‐associated vasculitis and anti‐GBM disease: A report of two cases
por: Le Moine, Camille, et al.
Publicado: (2021)

ANCA-Associated Vasculitis With Anti-GBM Disease and Two Types of Tumors: A Case Report
por: Li, Xiuxiu, et al.
Publicado: (2022)

Anti-hLAMP2-antibodies and dual positivity for anti-GBM and MPO-ANCA in a patient with relapsing pulmonary-renal syndrome
por: Etter, Christoph, et al.
Publicado: (2011)

Atypical anti-glomerular basement membrane disease with anti-GBM antibody negativity and ANCA positivity: a case report
por: Guo, Na, et al.
Publicado: (2021)

Overlap between dermatomyositis and ANCA vasculitides
por: Yuste, Claudia, et al.
Publicado: (2014)

A Rare Case of Pulmonary-Renal Syndrome With Triple-Seropositive for Myeloperoxidase-Anti-Neutrophil Cytoplasm Antibody (MPO-ANCA), Proteinase 3 (PR3)-ANCA and Anti-Glomerular Basement Membrane (GBM) Antibodies
por: Palha, Vanessa, et al.
Publicado: (2021)

Avoidance of Harm From Treatment for ANCA-Associated Vasculitis
por: King, Catherine, et al.
Publicado: (2017)

Anti-GBM-Nephritis
por: Windpessl, Martin, et al.
Publicado: (2023)

First, do no harm
por: Marler, Thomas E., et al.
Publicado: (2017)

First do not harm
por: Jamoulle, Marc
Publicado: (2015)

First do no harm
por: Huisman, Menno V., et al.
Publicado: (2022)

Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome
por: Draibe, Juliana, et al.
Publicado: (2015)

Systemic Lupus Erythematosus and ANCA-Associated Vasculitis Overlap Syndrome: A Case Report
por: Khil, Jaclyn, et al.
Publicado: (2022)

Successful treatment of steroid-refractory double-positive ANCA and anti-GBM disease with a combination of plasma exchange and immunosuppression: A case report and literature review
por: Uto, Kazuko, et al.
Publicado: (2018)

Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients
por: McAdoo, Stephen P., et al.
Publicado: (2017)

Anti-GBM disease with a mild relapsing course and low levels of anti-GBM autoantibodies
por: Segelmark, Mårten, et al.
Publicado: (2012)

On language – first, do no harm
por: Schumann, Roman
Publicado: (2022)

Draft Genome Sequences of Aggregatibacter actinomycetemcomitans Strains 310a and 310b
por: May, Anthony C., et al.
Publicado: (2017)

Transformation of membranous into anti-GBM nephritis
por: Imtiaz, S., et al.
Publicado: (2012)

Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm
por: Hsu, Yao-Chun, et al.
Publicado: (2023)

COVID-19: First Do No Harm
por: Waterer, Grant W., et al.
Publicado: (2020)

Anti-GBM disease with positive serum anti-GBM antibodies but negative IgG deposition: A case report
por: Kazemzadeh, Kimia, et al.
Publicado: (2023)

First Do No Harm With COVID-19: Corona Collateral Damage Syndrome
por: Stock, Lawrence, et al.
Publicado: (2020)

Do No Harm: Considerations for Pediatric Orthopaedic Practice During the Coronavirus Pandemic
por: Schaeffer, Emily K., et al.
Publicado: (2020)

“First do no harm” and the importance of prediction in oncology
por: Characiejus, Dainius, et al.
Publicado: (2010)

Advances in nanotechnology for the treatment of GBM
por: Wei, Dongyan, et al.
Publicado: (2023)

Blood transfusion and the lung: first do no harm?
por: Napolitano, Lena M
Publicado: (2011)

Diabetes Drug Therapy -- First Do No Harm
por: Curtiss, Frederic R., et al.
Publicado: (2008)

ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review
por: Wu, Rui, et al.
Publicado: (2021)

Benzenesulfonamide Analogs: Synthesis, Anti-GBM Activity and Pharmacoprofiling
por: Murugesan, Akshaya, et al.
Publicado: (2023)

Health Tract, No. 310: The Dead Wife
Publicado: (1867)

ANCA-associated vasculitis and IgG4-related disease overlap syndrome: a case report and literature review
por: Faz-Muñoz, David, et al.
Publicado: (2022)

Sun certification training guide (310-025, 310-027): Java 2 programmer and developer exams
por: Jaworski, Jamie
Publicado: (2002)

Podocyte Depletion in Thin GBM and Alport Syndrome
por: Wickman, Larysa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a28bkvll26krdmutbn44lkuuor